BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30919391)

  • 1. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
    Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S
    Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.
    Choi YM; Sung TY; Kim WG; Lee JJ; Ryu JS; Kim TY; Kim WB; Hong SJ; Song DE; Shong YK
    J Surg Oncol; 2015 Dec; 112(8):815-21. PubMed ID: 26464058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
    Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
    Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.
    Suh YJ; Choe JY; Park HJ
    Endocr Pathol; 2017 Jun; 28(2):159-164. PubMed ID: 28386672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.
    Hattori S; Miyajima A; Hirasawa Y; Kikuchi E; Kurihara I; Miyashita K; Shibata H; Nakagawa K; Oya M
    J Endourol; 2014 Jun; 28(6):686-92. PubMed ID: 24499341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.
    Hescot S; Curras-Freixes M; Deutschbein T; van Berkel A; Vezzosi D; Amar L; de la Fouchardière C; Valdes N; Riccardi F; Do Cao C; Bertherat J; Goichot B; Beuschlein F; Drui D; Canu L; Niccoli P; Laboureau S; Tabarin A; Leboulleux S; Calsina B; Libé R; Faggiano A; Schlumberger M; Borson-Chazot F; Mannelli M; Gimenez-Roqueplo AP; Caron P; Timmers HJLM; Fassnacht M; Robledo M; Borget I; Baudin E;
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2367-2374. PubMed ID: 30715419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
    Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
    Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.
    Khadilkar K; Sarathi V; Kasaliwal R; Pandit R; Goroshi M; Shivane V; Lila A; Bandgar T; Shah NS
    J Pediatr Endocrinol Metab; 2017 May; 30(5):575-581. PubMed ID: 28432847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry, genetics and therapy of malignant pheochromocytomas.
    Mannelli M
    Ann Endocrinol (Paris); 2009 Jun; 70(3):166-7. PubMed ID: 19286155
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
    Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
    Goffredo P; Sosa JA; Roman SA
    J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
    Roman-Gonzalez A; Zhou S; Ayala-Ramirez M; Shen C; Waguespack SG; Habra MA; Karam JA; Perrier N; Wood CG; Jimenez C
    Ann Surg; 2018 Jul; 268(1):172-178. PubMed ID: 28257320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era.
    Pillai S; Gopalan V; Smith RA; Lam AK
    Crit Rev Oncol Hematol; 2016 Apr; 100():190-208. PubMed ID: 26839173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene targeting through o-methylated catecholamine metabolite patterns.
    Shine B
    Clin Chem; 2011 Mar; 57(3):361-2. PubMed ID: 21245368
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.